Tetragon Financial Group
Limited 2023 Annual Report
LONDON, March 4, 2024 -- Tetragon has published its 2023
Annual Report. Please click below to access the report.
Tetragon Financial Group Limited 2023 Annual
Report
As a reminder, Tetragon will host a conference call for
investors on Tuesday, 5 March 2024 at
15:30 GMT / 10:30 EST to discuss its annual report and to
provide a company update.
During the call, Tetragon's investment manager will also
seek to address questions raised by investors, including questions
e-mailed to ir@tetragoninv.com.
Getting Access to the Call and
Q&A:
The call will be accompanied by a live presentation which
can be viewed online by registering at the link below. In addition,
questions can be submitted online while watching the presentation.
We would encourage you to log in 15 minutes prior to the start of
the call.
Webcast – please use the following link to register and
access the live event webcast:
https://onlinexperiences.com/Launch/QReg/ShowUUID=0C715F47-2B1D-4FE6-BBFF-BE95CD52F7A8
Audio conference – please use the following link to
register for your personal audio conference call details if you
cannot join the webcast:
https://register.vevent.com/register/BI6cb32f159c974b4da4e6a355e0c93eda
Presentation Replay:
A replay of the call will be available for 30 days through
the link provided above or by
visiting https://www.tetragoninv.com/events where a
recording will posted.
About Tetragon:
Tetragon is a Guernsey closed-ended investment company.
Its non-voting shares are listed on Euronext in Amsterdam, a regulated market of Euronext
Amsterdam N.V., and also traded on the Specialist Fund Segment of
the Main Market of the London Stock Exchange. Our investment
manager is Tetragon Financial Management LP. Find out more
at www.tetragoninv.com.
Tetragon's non-voting shares are subject to restrictions
on ownership by U.S. persons and are not intended for European
retail investors.
Please
see: https://www.tetragoninv.com/shareholders/additional-information.
Tetragon:Yuko
ThomasInvestor Relationsir@tetragoninv.com |
Press
Inquiries:Prosek PartnersPro-tetragon@prosek.comU.K. +44 20 3890
9193U.S. +1 212 279 3115 |
This release contains inside information
within the meaning of Article 7(1) of the EU Market Abuse
Regulation (2014/596/EU), or EU MAR, and of the UK version of EU
MAR as it forms part of UK law by virtue of the European Union
(Withdrawal) Act (as amended).
This release does not contain or constitute
an offer to sell or a solicitation of an offer to purchase
securities in the United States or any other
jurisdiction. The securities of Tetragon have not been and will not
be registered under the U.S. Securities Act of 1933, as amended,
and may not be offered or sold in the
United States or to U.S. persons unless they are registered
under applicable law or exempt from registration. Tetragon does not
intend to register any portion of its securities in the United States or to conduct a public offer
of securities in the United
States. In addition, Tetragon has not been and will not be
registered under the U.S. Investment Company Act of 1940, as
amended, and investors will not be entitled to the benefits of such
Act. Tetragon is registered in the public register of the
Netherlands Authority for the Financial Markets (Autoriteit
Financiële Markten) under Section 1:107 of the Dutch Financial
Markets Supervision Act as an alternative investment fund from a
designated state.